《全日总结》恒指升137点 科网及药股扬 国药弹9%
市场憧憬美经济V型反弹,道指昨晚升526点或2%。亚太区股市昨日(16日)急升後靠稳,港股反覆上升。恒指高开19点後,早段曾倒跌148点曾低见24,195点,午後造好,最终全日升137点或0.6%,收24,481点;国指升42点或0.4%,报9,909点。大市全日成交总额缩减至1,042.42亿元,沪、深港通南下交易半日录得净流入金额分别为17.52亿及16.81亿元人民币。
医药股造好,报道指国药中生疫苗抗体结果理想,国药(01099.HK)股价急升9.2%报20.75元,为升幅最大国指成分股。其他医药股上升,中生制药(01177.HK)升4.7%。绿叶制药(02186.HK)、四环(00460.HK)及复星医药(02196.HK)各升8.3%、7.2%及6.5%,白云山(00874.HK)升3.8%,石药(01093.HK)、中国中药(00570.HK)及华润医药(03320.HK)各升2.3%至2.9%。
科技股普遍上升,阿里巴巴(09988.HK)升2.2%报217.8元,腾讯(00700.HK)升0.4%报450.6元,美团点评(03690.HK)破顶後曾倒,收市升0.2%报172.4元,盘中见175.9元新高。中印边境军事冲突,着力印度市场的小米(01810.HK)跌3.1%报12.5元。网易(09999.HK)则跌1.2%报128.1元。此外,IGG(00799.HK)及阅文(00772.HK)各升5%及8%,擎天软件(01297.HK)急升11%,微盟(02013.HK)创上市新高後倒跌2.2%。
手机部件股偏软,瑞声(02018.HK)跌0.9%,鸿腾(06088.HK)及通达(00698.HK)各跌3.3%及4.4%。电讯设备股中兴(00763.HK)回吐2.8%。晶片股逆市上扬,中芯(00981.HK)及华虹半导体(01347.HK)各升1.6%及3.3%,晶片设备股ASM太平洋(00522.HK)升2.5%重上80元。
其他蓝筹股方面,汇控(00005.HK)升0.8%报37.7元,友邦(01299.HK)升1.8%报71.9元。港交所(00388.HK)受制300元关口,收跌0.7%报293.6元。内银股中行(03988.HK)及内险股国寿(02628.HK)各升0.7%及0.4%。
山东黄金(01787.HK)遭加拿大金矿商巴力克沽售7,930万股,套现逾16亿元。该股跌3.4%报21.3元。政府取消食肆每桌人数上限,本地快餐股大家乐(00341.HK)升6.7%,大快活(00052.HK)亦升3%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.